| pubmed-article:11029600 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C0001924 | lld:lifeskim |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C0221102 | lld:lifeskim |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C0027726 | lld:lifeskim |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C0036773 | lld:lifeskim |
| pubmed-article:11029600 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:11029600 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11029600 | pubmed:dateCreated | 2000-11-9 | lld:pubmed |
| pubmed-article:11029600 | pubmed:abstractText | Hyperlipidemia is a common feature of the nephrotic syndrome (NS). From retrospective studies, it has been suggested that aggressive lipid-lowering with low-density lipoprotein apheresis (LDL-A) may not only improve dyslipidemia but also decrease urinary albumin excretion and increase serum levels of albumin in patients with focal segmental sclerosis. | lld:pubmed |
| pubmed-article:11029600 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11029600 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11029600 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11029600 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11029600 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11029600 | pubmed:issn | 0014-2972 | lld:pubmed |
| pubmed-article:11029600 | pubmed:author | pubmed-author:AlvestrandAA | lld:pubmed |
| pubmed-article:11029600 | pubmed:author | pubmed-author:ErikssonMM | lld:pubmed |
| pubmed-article:11029600 | pubmed:author | pubmed-author:AngelinBB | lld:pubmed |
| pubmed-article:11029600 | pubmed:author | pubmed-author:StenvinkelPP | lld:pubmed |
| pubmed-article:11029600 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11029600 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:11029600 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11029600 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11029600 | pubmed:pagination | 866-70 | lld:pubmed |
| pubmed-article:11029600 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:meshHeading | pubmed-meshheading:11029600... | lld:pubmed |
| pubmed-article:11029600 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11029600 | pubmed:articleTitle | LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion. | lld:pubmed |
| pubmed-article:11029600 | pubmed:affiliation | Huddinge University Hospital, Stockholm, Sweden. peter.stenvinkel@klinvet.ki.se | lld:pubmed |
| pubmed-article:11029600 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11029600 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11029600 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11029600 | lld:pubmed |
